Attached files
file | filename |
---|---|
EX-32.2 - IGAMBIT CERTIFICATION - Clinigence Holdings, Inc. | exhibit322.htm |
XML - IDEA: XBRL DOCUMENT - Clinigence Holdings, Inc. | R9999.htm |
EX-32.1 - IGAMBIT CERTIFICATION - Clinigence Holdings, Inc. | exhibit321.htm |
EX-31.1 - IGAMBIT CERTIFICATION - Clinigence Holdings, Inc. | exhibit311.htm |
10-K - IGAMBIT 10-K DEC 2015 - Clinigence Holdings, Inc. | f2015igambitform10kdraft4132.htm |
Exhibit 31.2
CHIEF FINANCIAL OFFICER CERTIFICATION
PURSUANT TO SECTION 302
I, Elisa Luqman, certify that:
1. I have reviewed this Annual Report on Form 10-K of iGambit Inc. (the Registrant);
2. Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the
period covered by this report.
3. Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition, results
of operations and cash flows of the Registrant as of, and for, the periods presented in this
report;
4. The Registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-
15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material
information relating to the Registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which
this report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted
accounting principles;
c) evaluated the effectiveness of the Registrants disclosure controls and procedures
presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on
such evaluation; and
d) disclosed in this report any change in the Registrants internal control over financial
reporting that occurred during the Registrants most recent fiscal quarter (the
Registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the Registrants internal control
over financial reporting; and
5. The Registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the Registrants auditors and the
audit committee of Registrants board of directors (or persons performing the equivalent
functions):
a) all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely
affect the Registrants ability to record, process, summarize and report financial
information; and
b) any fraud, whether or not material, that involves management or other employees who
have a significant role in the Registrants internal control over financial reporting.
Date: April 14, 2016
/s/ Elisa Luqman
Elisa Luqman
Chief Financial Officer
(Principal Financial Officer)